Aortic Stenosis

Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29(3):630-634. doi:10.1016/s0735- 1097(96)00563-3 3. Otto CM, Nishimura RA, Bonow RO, et al: 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143(5):e35â€“e71, 2021. doi: 10.1161/CIR.0000000000000932 4. Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol 2010;55(25):2789-2800. doi:10.1016/j.jacc.2009.12.068 Pathophysiology of Aortic Stenosis Aortic stenosis causes an increased pressure load on the left ventricle (LV), resulting in compensatory hypertrophy without cavity enlargement (concentric hypertrophy). In early disease stages, there is an increased pressure gradient from the high-pressure LV to the lower pressure aorta. With time, the ventricle can no longer compensate and begins to fail, with secondary LV cavity enlargement, reduced 2/12 ejection fraction (EF), decreased cardiac output, and a misleadingly low gradient across the aortic valve (low-gradient severe AS) as the LV can no longer generate as high of a systolic pressure. Aortic regurgitation accompanies aortic stenosis in approximately 7% of patients (1), and about half of patients with severe AS also have mitral annular calcification (2,
